Fineline Cube

Follow:
14436 Articles
Fujian Cosunter Gains Ethics Approval for Phase III Study of Neracorvir in CHB Patients
CompanyDrug

Fujian Cosunter Gains Ethics Approval for Phase III Study of Neracorvir in CHB Patients

CDE Accepts NDA for Ark Bio's Azstarys, a Priority-Reviewed ADHD Treatment
CompanyDrug

CDE Accepts NDA for Ark Bio’s Azstarys, a Priority-Reviewed ADHD Treatment

Ascentage Pharma Highlights Hematology Advances at EHA 2025, Focus on Olverembatinib and APG-5918
CompanyDrug

Ascentage Pharma Highlights Hematology Advances at EHA 2025, Focus on Olverembatinib and APG-5918

Clover Biopharmaceuticals Terminates Adimmune Influenza Vaccine Pact Over Market Shifts
CompanyDeals

Clover Biopharmaceuticals Terminates Adimmune Influenza Vaccine Pact Over Market Shifts

Fosun Pharma's Serplulimab Approved in Singapore and Malaysia for ES-SCLC Treatment
CompanyDrug

Fosun Pharma’s Serplulimab Approved in Singapore and Malaysia for ES-SCLC Treatment

China's NHC Unveils 2025 Healthcare Reforms to Tackle Procurement and Service Irregularities
Policy / Regulatory

China’s NHC Unveils 2025 Healthcare Reforms to Tackle Procurement and Service Irregularities

Thermo Fisher Mulls $4B Diagnostic Business Sale Amid Healthcare Sector Turbulence
CompanyDeals

Thermo Fisher Mulls $4B Diagnostic Business Sale Amid Healthcare Sector Turbulence

Changchun High-Tech Subsidiary Gains NMPA Approval for CINV Drug Trial
CompanyDrug

Changchun High-Tech Subsidiary Gains NMPA Approval for CINV Drug Trial

Novo Nordisk Advances Amycretin for Weight Management in Phase III Trials
CompanyDrug

Novo Nordisk Advances Amycretin for Weight Management in Phase III Trials

FDA OKs MSD's Keytruda for Perioperative Head and Neck Cancer Treatment With PD-L1 Expression
CompanyDrug

FDA OKs MSD’s Keytruda for Perioperative Head and Neck Cancer Treatment With PD-L1 Expression

GSK Seeks EMA Approval to Expand RSV Vaccine Arexvy Use to Adults Aged 18+
CompanyDrug

GSK Seeks EMA Approval to Expand RSV Vaccine Arexvy Use to Adults Aged 18+

UCB Announces Investment in U.S. Biologics Production Facility
Company

UCB Announces Investment in U.S. Biologics Production Facility